News

Endpoints News46m
Avadel can pur­sue la­bel ex­pan­sion for nar­colep­sy drug Lum­ryz af­ter court rul­ing
Federal appeals court overturns order blocking Avadel Pharmaceuticals from seeking FDA approval for Lumryz in idiopathic ...
Endpoints News48m
From deal to dis­as­ter: Drug­mak­ers face a changed Wash­ing­ton as Trump em­braces ‘most fa­vored na­tion’ prices
President Trump met with pharma CEOs at the White House. After praising investments, a 'most favored nation' drug pricing ...